Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 2021-05-23 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +0.61% | +2.88% | +45.63% | +0.39% | 83.24B | |
| -0.69% | +3.58% | -19.85% | -35.64% | 59.49B | |
| +14.36% | +152.27% | +526.55% | +41.90% | 63.41B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 52.94B | |
| +1.86% | +3.13% | +11.49% | +174.36% | 49.86B | |
| +1.21% | +3.87% | +61.90% | -16.51% | 32.62B | |
| +1.36% | +5.06% | +53.04% | +103.13% | 26.29B | |
| +9.99% | +11.86% | +14.78% | +216.26% | 22.23B | |
| +3.89% | +1.08% | +61.82% | +112.10% | 17.22B | |
| Average | +3.32% | +20.50% | +83.94% | +70.24% | 45.26B | |
| Weighted average by Cap. | +3.47% | +27.36% | +101.62% | +49.32% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.86M 2.68M 2.45M 4.62M 318M 4.67M 31.62M 12.31M 161M 12.54M 12.26M 532M | 6.18M 5.3M 4.96M 4.53M 8.55M 589M 8.64M 58.53M 22.78M 297M 23.2M 22.7M 984M |
| Net income | 1.4M 1.2M 1.13M 1.03M 1.94M 134M 1.96M 13.28M 5.17M 67.45M 5.27M 5.15M 223M | 2.41M 2.06M 1.93M 1.77M 3.34M 230M 3.37M 22.82M 8.88M 116M 9.05M 8.85M 384M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
